The innovative biopharmaceutical industry, a lever for economic and social well-being. A comprehensive approach.

The innovative biopharmaceutical industry, a lever for economic and social well-being. A comprehensive approach”, organized by Foment del Treball.Foment del Treball

On Tuesday, Wednesday 29, our CEO, Meritxell Teixidó, will participate in the session “The innovative biopharmaceutical industry, a lever for economic and social well-being. A comprehensive approach”, organized by Foment del Treball.

The aim of this event is to address issues such as the future of research and innovation, the strengthening of drug production, security and strategic autonomy, through the participation and debate of institutional representatives, experts, professionals and biopharmaceutical companies.

An opportunity to create a constructive dialogue between the actors of the biopharmaceutical sector by sharing knowledge, experiences and opinions to promote innovation, which results in the improvement of health care, economic development and the well-being of the population.

➡️ Register here

/by
You might also like
Three University of Barcelona spin-offs led by women will receive funding as part of the Women TechEU pilot callFundació Bosch i GimperaThree University of Barcelona spin-offs will receive funding from Women TechEU pilot call
Technology closer to young patientsG2BTechnology closer to young patients
Meritxell Teixidó això de semblar una superwomen em patina moltDiari AraI couldn’t care less about looking like a “superwoman”
Womenstartupawardsgate2BrainWomenStarUpAwards
GATE2BRAIN winner of the Barcelona Activa Pre-acceleration competitionBarcelona ActivaGATE2BRAIN WINNER OF THE BARCELONA ACTIVA PRE-ACCELERATION COMPETITION
PaidhosGate2Brain wants to deliver drugs to the brain to combat intact barrier brain tumors, such as DIPG
Una tecnología para ayudar a tratar el cáncer infantilgate2brainA technology to help treat pediatric cancer
Within the framework of the discussion-based interview series, Exploration Science, in which scientists talk about their ventures and areas of expertise, our CEO, Dr. Meritxell Teixidó, and the first and only APS American Peptide Idol joined @CEM's Dr. Wendy Hartsock to discuss the work @Gate2Brain is doing in pediatric oncology, dive into the technology, and talk about empathetic leadership and the power of diversity.CEMExploration Science with Dr. Wendy Harsock
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

Technology closer to young patientsTechnology closer to young patientsG2BCataloniaBio & Health Teach GalaG2BCataloniaBio HT Gala 2023